Before you sell to, join or invest in ILIAD BIOTECHNOLOGIES, INC.
MentionFox check on ILIAD BIOTECHNOLOGIES, INC.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/iliad-biotechnologies-inc-form-d-26000001
Check ILIAD BIOTECHNOLOGIES, INC. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about ILIAD BIOTECHNOLOGIES, INC.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
ILIAD BIOTECHNOLOGIES, INC. filed a Form D with the Securities and Exchange Commission on 2026-02-20.
ILIAD BIOTECHNOLOGIES, INC. filed a Form D notice of an exempt securities offering with the SEC on February 20, 2026. The filing reports $115.54M sold. Its industry group is Biotechnology. It names Keith Rubin (Executive Officer, Director), Mario Barro (Director), Avi Naider (Director) (SEC Form D, February 20, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like ILIAD BIOTECHNOLOGIES, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-02-20 · the record
Pitching, partnering or investing alongside them? See who really runs and owns ILIAD BIOTECHNOLOGIES, INC.
Free to see. No signup.
More on the people and the money behind ILIAD BIOTECHNOLOGIES, INC., from the filings we hold.
Biotechnology raises by companies based in Florida, filed in February 2026, largest first.
Get an email when ILIAD BIOTECHNOLOGIES, INC. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when ILIAD BIOTECHNOLOGIES, INC. raises, hires or launches. No email unless you switch it on.
Watch ILIAD BIOTECHNOLOGIES, INC. →Get the full cited report on ILIAD BIOTECHNOLOGIES, INC.
What the filing shows about ILIAD BIOTECHNOLOGIES, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on ILIAD BIOTECHNOLOGIES, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives ILIAD BIOTECHNOLOGIES, INC.'s address as 4581 Weston Road, Suite 260, Weston, FL 33331.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on ILIAD BIOTECHNOLOGIES, INC. See pricing
ILIAD BIOTECHNOLOGIES, INC. is a registered filer with the SEC (CIK 2112659) and has filed since 2026-02-20. 1 filing is on record, the latest on 2026-02-20.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
ILIAD BIOTECHNOLOGIES, INC.'s Form D of 2026-02-20 names Keith Rubin, Mario Barro, Avi Naider and 2 more as its officers, directors or promoters.
Its new offerings report $115.54M sold across 1 offering, as its own filings state.
Trailing twelve months. 766 filings in Biotechnology, totalled by week. The dot is this raise, $115.54M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
ILiAD Biotechnologies is a clinical stage biotechnology company dedicated to the prevention and treatment of diseases caused by Bordetella Pertussis. Our lead candidate, BPZE1, represents the most advanced next generation pertussis vaccine, successfully completing two Phase 2 clinical trials. Join us in advancing public health through innovative vaccine solutions.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Keith Rubin is named as Executive Officer and Director on the Form D that ILIAD BIOTECHNOLOGIES, INC. filed with the SEC on 20 February 2026, one of 5 people that filing names.
Mario Barro is named as Director on the Form D that ILIAD BIOTECHNOLOGIES, INC. filed with the SEC on 20 February 2026, one of 5 people that filing names.
Avi Naider is named as Director on the Form D that ILIAD BIOTECHNOLOGIES, INC. filed with the SEC on 20 February 2026, one of 5 people that filing names.
Eric Edidin is named as Director on the Form D that ILIAD BIOTECHNOLOGIES, INC. filed with the SEC on 20 February 2026, one of 5 people that filing names.
William Steinkrauss is named as Executive Officer on the Form D that ILIAD BIOTECHNOLOGIES, INC. filed with the SEC on 20 February 2026, one of 5 people that filing names.
5 people named on the filing — 2 holding an executive role and 3 as directors only.
Named as of the 2026-02-20 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about ILIAD BIOTECHNOLOGIES, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on ILIAD BIOTECHNOLOGIES, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on ILIAD BIOTECHNOLOGIES, INC. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist ILIAD BIOTECHNOLOGIES, INC.You get an alert in MentionFox the next time this company shows up.
If you're behind ILIAD BIOTECHNOLOGIES, INC.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-04 (iliadbio.com).
Each opens in a new tab, filled in for ILIAD BIOTECHNOLOGIES, INC.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Miami
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/iliad-biotechnologies-inc-form-d-26000001